You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

New Frontiers in Psychiatry

  • Authors: Scott T. Aaronson, MD; Hansa Bhargava, MD; Sanjay Gupta, MD; Gregory W. Mattingly, MD; Sagar V. Parikh, MD, FRCPC; Sidney Zisook, MD
  • CME / ABIM MOC / CE Released: 7/8/2022
  • Valid for credit through: 7/8/2023
Start Activity

  • Credits Available

    Physicians - maximum of 1.75 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 1.75 ABIM MOC points

    Nurses - 1.75 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for psychiatrists, primary care physicians (PCPs), pediatricians, nurses, nurse practitioners (NPs), and physician assistants (PAs).

The goal of this activity is that learners will be better able to understand the available evidence for innovative approaches to the diagnosis and management of psychiatric conditions.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Role of evidence-based digital tools in the diagnosis and treatment of psychiatric disorders  
    • Available clinical data on pharmacogenomic considerations for clinical management of psychiatric conditions  
    • Recent clinical data on the use of psilocybin in specific psychiatric disorders   
  • Demonstrate greater confidence in their ability to
    • Implement strategies to improve resilience in oneself or patients


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Scott T. Aaronson, MD

    Chief Science Officer 
    Institute for Advanced Diagnostics and Therapeutics 
    Sheppard Pratt 
    Adjunct Professor of Psychiatry 
    University of Maryland School of Medicine  
    Baltimore, Maryland  

    Disclosures

    Scott T. Aaronson, MD, has the following relevant financial relationships:  
    Consultant or advisor for: Compass Pathways; Janssen; LivaNova; Neuronetics; Sage Therapeutics 
    Research funding from: Compass Pathways; Neuronetics 
    Contracted researcher for: Compass Pathways; Janssen; LivaNova; Neurolief 

  • Hansa Bhargava, MD

    Chief Medical Officer 
    Senior Medical Director/Correspondent 
    Medscape 
    Senior Medical Director 
    WebMD 
    Attending Physician 
    Children's Healthcare of Atlanta 
    Emory University 
    Atlanta, Georgia 

    Disclosures

    Hansa Bhargava, MD, has the following relevant financial relationships:  
    Consultant or advisor for: Cognoa; Freespira 

  • Sanjay Gupta, MD

    Chief Medical Officer 
    BryLin Behavioral Health System 
    Buffalo, New York 
    Medical Director 
    Geriatric and Adult Psychiatry 
    Endeavor Clinic 
    Buffalo, New York 
    Consulting Psychiatrist 
    DENT Neurological Institute 
    Amherst, New York 
    Clinical Professor 
    Department of Psychiatry 
    SUNY at Buffalo 
    Clinical Professor 
    Department of Psychiatry 
    SUNY Upstate Medical University at Syracuse 
    Syracuse, New York 

    Disclosures

    Sanjay Gupta, MD, has the following relevant financial relationships:  
    Consultant or advisor for: Intra-Cellular Therapies 
    Speaker or member of speakers bureau for: AbbVie; Alkermes; Intra-Cellular Therapies; Janssen; Neurocrine; Otsuka; Sunovion 

  • Gregory W. Mattingly, MD

    Associate Clinical Professor  
    Washington University School of Medicine  
    President, Midwest Research Group  
    President-Elect  
    APSARD - American Professional Society for ADHD and Related Disorders  
    St. Louis, Missouri

    Disclosures

    Gregory W. Mattingly, MD, has the following relevant financial relationships: 
    Consultant or advisor for: AbbVie; Acadia; Alkermes; Axsome; Eisai; Ironshore; Intra-Cellular Therapies; Janssen; Lundbeck; Neos; Neurocrine; Otsuka; Redax; Roche; Rhodes; Sage; Shire; Sunovion; Supernus; Takeda; Teva; Trispharma  
    Speaker or member of speakers bureau for: AbbVie; Alkermes; Eisai; Janssen; Lundbeck; Neurocrine; Otsuka; Sunovion; Supernus; Takeda; Trisphama  
    Contracted researcher for: AbbVie; Acadia; Alkermes; Avanir; Axsome; Boehringer Ingelheim; Emalex; Janssen; Medgenics; NLS1 Pharma AG; Redax; Roche; Sage; Shire; Sunovion; Supernus; Takeda; Teva

  • Sagar V. Parikh, MD, FRCPC

    John F. Greden Professor of Depression 
    and Clinical Neuroscience 
    Professor of Psychiatry 
    Michigan Medicine 
    University of Michigan, Ann Arbor 
    Ann Arbor, Michigan 

    Disclosures

    Sagar V. Parikh, MD, FRCPC, has the following relevant financial relationships:  
    Consultant or advisor for: Aifred; Janssen; Myriad; Neonmind; Sage; Takeda 
    Speaker or member of speakers bureau for: Otsuka 
    Research funding from: Aifred; Janssen; Merck; Sage 
    Owns stock (publicly traded) in: Neonmind

  • Sidney Zisook, MD

    Distinguished Professor of Psychiatry 
    Director, San Diego Residency Training Program 
    University of California 
    San Diego, California 

    Disclosures

    Sidney Zisook, MD, has the following relevant financial relationships:  
    Research funding from: Compass Ltd.

Editor

  • Clinton W. Wright, Pharm.D., BCPP

    Medical Education Director, Medscape, LLC

    Disclosures

    Clinton W. Wright, Pharm.D., BCPP, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC 

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships. 

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

    For Nurses

  • Awarded 1.75 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

New Frontiers in Psychiatry

Authors: Scott T. Aaronson, MD; Hansa Bhargava, MD; Sanjay Gupta, MD; Gregory W. Mattingly, MD; Sagar V. Parikh, MD, FRCPC; Sidney Zisook, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 7/8/2022

Valid for credit through: 7/8/2023

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

What's the Deal With Digital?​ Understanding the Power and Potential of Digital Therapeutics in Mental Health Care

Learn more about digital products in mental health care.
Sanjay Gupta, MD

Exploring the Clinical Utility of Pharmacogenomics

Learn how to use pharmacogenomics in your clinic.
Sagar V. Parikh, MD, FRCPC

The Promises and Perils ​of Psilocybin in Psychiatry: ​A Clinical Debate

Hear the clinical updates on the use of psilocybin in psychiatry.
Scott T. Aaronson, MD; Sidney Zisook, MD

The Neurobiology of Resilience

Learn more about improving your and your patients' resilience.
Gregory W. Mattingly, MD
 

Educational Impact Challenge

The goal of this activity is that learners will be better able to understand the available evidence for innovative approaches to the diagnosis and management of psychiatric conditions.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.